newsfilter
← Latest News
PR Newswire·

Cellular Biomedicine Group to Report Third Quarter 2019 Results on November 6, 2019

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...